BIO-key International Inc. (NASDAQ:BKYI – Get Free Report) shares passed above its 50-day moving average during trading on Friday . The stock has a 50-day moving average of $0.76 and traded as high as $0.80. BIO-key International shares last traded at $0.77, with a volume of 74,785 shares traded.
Analyst Upgrades and Downgrades
Separately, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of BIO-key International in a research note on Friday. One analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the stock presently has an average rating of “Sell”.
Read Our Latest Stock Report on BKYI
BIO-key International Price Performance
BIO-key International (NASDAQ:BKYI – Get Free Report) last released its quarterly earnings data on Wednesday, August 13th. The technology company reported ($0.20) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.15) by ($0.05). The company had revenue of $1.70 million for the quarter, compared to analysts’ expectations of $1.70 million. BIO-key International had a negative net margin of 60.92% and a negative return on equity of 92.10%.
About BIO-key International
BIO-key International, Inc develops and markets fingerprint identification biometric technology and software solutions, and enterprise-ready identity access management solutions for commercial, government, and education customers in the United States and internationally. The company offers BIO-key PortalGuard and PortalGuard IDaaS solutions, a customer-controlled and neutral-by-design cloud-based identity platform that allows customers to integrate with any cloud or on-premises SaaS application, as well as windows device authentication through IAM platform.
Read More
- Five stocks we like better than BIO-key International
- What is a Dividend Harvesting Strategy and How Can Investors Profit from it?
- Rayonier-PotlatchDeltic Merger Signals Industry Upside
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Hims & Hers Short Interest Nears All-Time High, Buy The Dip?
- Quiet Period Expirations Explained
- This Defense Stock Has a $57B Backlog and New AI Tailwinds
Receive News & Ratings for BIO-key International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BIO-key International and related companies with MarketBeat.com's FREE daily email newsletter.
